Nectin-4
39 programs · 38 companies
Programs
39
Companies
38
Active Trials
22
Targeting Nectin-4
| Drug | Company | Phase | MOA | Indications |
|---|---|---|---|---|
| MRK-2473 | Merck & Co | Phase 1/2 | AMLNB | |
| DSN-1421 | Daiichi Sankyo | Phase 3 | PsAET | |
| ION-3857 | Ionis | Preclinical | CKDHS | |
| Semasacituzumab | Illumina | Phase 3 | Celiac | |
| Elrainavolisib | Roivant Sciences | Preclinical | LGS | |
| IDY-3466 | Ideaya Bio | NDA/BLA | IgANHCC | |
| Gozelucimab | Eisai | Phase 1/2 | MDDET | |
| CIP-213 | Cipla | Approved | Gastric CaAtopic Derm | |
| UCS-IIT-783 | UCSF | NDA/BLA | Breast Ca | |
| Miriinavolisib | ImmunoGen (AbbVie) | Phase 3 | MDDPBC | |
| KAR-4717 | Kartos Ther | Preclinical | ADPKD | |
| Lisosertib | Athira Pharma | Phase 1 | AngelmanFTD | |
| BSG-8809 | BioSig Technologies | Approved | PTSDHeart Failure | |
| CLO-5164 | Clovis Oncology | Phase 1 | LGS | |
| ONS-2940 | OncoBiologics | Phase 2 | SCLCCervical Ca | |
| REA-1693 | Reata Pharma (Biogen) | Preclinical | NMOSD | |
| KNS-8287 | Kiniksa Pharma | Phase 2 | Wet AMDFL | |
| GLT-1490 | Galecto | Phase 1 | ADPKD | |
| 300-9245 | Betta Pharma | NDA/BLA | SMAGIST | |
| NTR-7700 | Natera | Phase 1/2 | FSGSAsthma | |
| NTR-8128 | Natera | Phase 3 | ALSMeso | |
| Elratapinarof | Maplewood Bio | Preclinical | Gastric Ca | |
| PPL-6055 | Piramal Pharma | Phase 2/3 | MigraineCRC | |
| 4D-4097 | 4D Pharma | Approved | AngelmanMyelofibrosis | |
| IMM-6534 | Immunicum | Phase 1/2 | TTR AmyloidosisMDD | |
| Capiderotide | Immatics | Phase 2 | EoEWet AMD | |
| Elrarapivir | Knight Ther | Phase 2 | NB | |
| SUP-6530 | Supernus Pharma | NDA/BLA | Alzheimer's | |
| Tezecapivasertib | Dare Bioscience | Phase 2 | Ewing Sarcoma | |
| Teracagene | Zydus Lifesciences | Phase 2 | ET | |
| Pexavorutinib | EMS Pharma | Phase 1/2 | EoEADHD | |
| Semafutibatinib | Biolab Pharma | Phase 3 | RettCrohn's | |
| BIO-IIT-463 | Bio-Manguinhos | Approved | Heart Failure | |
| CAM-IIT-965 | CAMS Peking Union | Phase 1 | Crohn's | |
| RAB-IIT-267 | Rabin Medical Center | Approved | MCL | |
| Bemasertib | Zhejiang Hisun | Phase 3 | Heart Failure | |
| Darasertib | Grünenthal | Phase 1 | MigraineMDD | |
| ZTS-4049 | Zoetis | Phase 2 | HNSCCADHD | |
| Doxabrutinib | Vetoquinol | Phase 2 | ADHD |